anti kv11 1  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs anti kv11 1
    Dominant-negative (DN)-Rab11B-green fluorescent protein (GFP) and Rab11B short hairpin (sh)RNA increases <t>WT-Kv11.1</t> and Bap31 colocalization. A : representative fluorescent images of cells coexpressing WT-Kv11.1 and Rab11B-GFP or DN-Rab11B-GFP immunostained
    Anti Kv11 1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti kv11 1/product/Alomone Labs
    Average 94 stars, based on 4 article reviews
    Price from $9.99 to $1999.99
    anti kv11 1 - by Bioz Stars, 2022-10
    94/100 stars

    Images

    1) Product Images from "Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum"

    Article Title: Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum

    Journal: American Journal of Physiology - Cell Physiology

    doi: 10.1152/ajpcell.00406.2012

    Dominant-negative (DN)-Rab11B-green fluorescent protein (GFP) and Rab11B short hairpin (sh)RNA increases WT-Kv11.1 and Bap31 colocalization. A : representative fluorescent images of cells coexpressing WT-Kv11.1 and Rab11B-GFP or DN-Rab11B-GFP immunostained
    Figure Legend Snippet: Dominant-negative (DN)-Rab11B-green fluorescent protein (GFP) and Rab11B short hairpin (sh)RNA increases WT-Kv11.1 and Bap31 colocalization. A : representative fluorescent images of cells coexpressing WT-Kv11.1 and Rab11B-GFP or DN-Rab11B-GFP immunostained

    Techniques Used: Dominant Negative Mutation

    Pharmacological correction of Kv11.1 current ( I Kv11.1 ) occurs in cells treated with cycloheximide and after 30 min. A : representative I Kv11.1 traces recorded from cells expressing G601S in control conditions ( n = 8 cells) and after E-4031 treatment without
    Figure Legend Snippet: Pharmacological correction of Kv11.1 current ( I Kv11.1 ) occurs in cells treated with cycloheximide and after 30 min. A : representative I Kv11.1 traces recorded from cells expressing G601S in control conditions ( n = 8 cells) and after E-4031 treatment without

    Techniques Used: Expressing

    G601S and Bap31 show a similar sensitivity to brefeldin a (bfa) and nocodazole (noc). A – D : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column), anti-Bap31 (green, second column), and anti-ERGIC-53
    Figure Legend Snippet: G601S and Bap31 show a similar sensitivity to brefeldin a (bfa) and nocodazole (noc). A – D : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column), anti-Bap31 (green, second column), and anti-ERGIC-53

    Techniques Used: Expressing

    G601S selectively colocalizes with Bap31. Shown are representative fluorescent images of cells expressing wild-type (WT)-Kv11.1 or G601S immunostained with anti-Kv11.1 (red, first column) and anti-Derlin-1 ( A ), anti-Bap31 ( B ), anti-Sec31 ( C ), or anti-ERGIC-53
    Figure Legend Snippet: G601S selectively colocalizes with Bap31. Shown are representative fluorescent images of cells expressing wild-type (WT)-Kv11.1 or G601S immunostained with anti-Kv11.1 (red, first column) and anti-Derlin-1 ( A ), anti-Bap31 ( B ), anti-Sec31 ( C ), or anti-ERGIC-53

    Techniques Used: Expressing

    E-4031 treatment decreases G601S and Bap31 colocalization. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second column) in control conditions ( n = 30 images) and
    Figure Legend Snippet: E-4031 treatment decreases G601S and Bap31 colocalization. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second column) in control conditions ( n = 30 images) and

    Techniques Used: Expressing

    Pharmacological correction increases the terminal glycosylation of G601S in cells treated with cycloheximide. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second
    Figure Legend Snippet: Pharmacological correction increases the terminal glycosylation of G601S in cells treated with cycloheximide. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second

    Techniques Used: Expressing

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Alomone Labs anti kv11 1
    Dominant-negative (DN)-Rab11B-green fluorescent protein (GFP) and Rab11B short hairpin (sh)RNA increases <t>WT-Kv11.1</t> and Bap31 colocalization. A : representative fluorescent images of cells coexpressing WT-Kv11.1 and Rab11B-GFP or DN-Rab11B-GFP immunostained
    Anti Kv11 1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti kv11 1/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti kv11 1 - by Bioz Stars, 2022-10
    93/100 stars
      Buy from Supplier

    90
    Alomone Labs kv11 1 channel
    Immunohistochemistry of the <t>Kv11.1</t> channels in the placental arteries of women who gave birth without or with COVID-19 during pregnancy. (A-C) Immunohistochemistry images of three women who gave birth without contracting COVID-19 (40 weeks of gestation). (D-F) Immunohistochemistry images of three women who gave birth (40 weeks of gestation), but contracted COVID-19 at 28, 32, or 36 weeks of gestation. Magnification x200. Arrows indicate remodeled vessels.
    Kv11 1 Channel, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kv11 1 channel/product/Alomone Labs
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    kv11 1 channel - by Bioz Stars, 2022-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Dominant-negative (DN)-Rab11B-green fluorescent protein (GFP) and Rab11B short hairpin (sh)RNA increases WT-Kv11.1 and Bap31 colocalization. A : representative fluorescent images of cells coexpressing WT-Kv11.1 and Rab11B-GFP or DN-Rab11B-GFP immunostained

    Journal: American Journal of Physiology - Cell Physiology

    Article Title: Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum

    doi: 10.1152/ajpcell.00406.2012

    Figure Lengend Snippet: Dominant-negative (DN)-Rab11B-green fluorescent protein (GFP) and Rab11B short hairpin (sh)RNA increases WT-Kv11.1 and Bap31 colocalization. A : representative fluorescent images of cells coexpressing WT-Kv11.1 and Rab11B-GFP or DN-Rab11B-GFP immunostained

    Article Snippet: Cells not expressing Kv11.1 did not show any immunostaining with anti-Kv11.1 (data not shown) nor any of the secondary antibodies alone (data not shown).

    Techniques: Dominant Negative Mutation

    Pharmacological correction of Kv11.1 current ( I Kv11.1 ) occurs in cells treated with cycloheximide and after 30 min. A : representative I Kv11.1 traces recorded from cells expressing G601S in control conditions ( n = 8 cells) and after E-4031 treatment without

    Journal: American Journal of Physiology - Cell Physiology

    Article Title: Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum

    doi: 10.1152/ajpcell.00406.2012

    Figure Lengend Snippet: Pharmacological correction of Kv11.1 current ( I Kv11.1 ) occurs in cells treated with cycloheximide and after 30 min. A : representative I Kv11.1 traces recorded from cells expressing G601S in control conditions ( n = 8 cells) and after E-4031 treatment without

    Article Snippet: Cells not expressing Kv11.1 did not show any immunostaining with anti-Kv11.1 (data not shown) nor any of the secondary antibodies alone (data not shown).

    Techniques: Expressing

    G601S and Bap31 show a similar sensitivity to brefeldin a (bfa) and nocodazole (noc). A – D : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column), anti-Bap31 (green, second column), and anti-ERGIC-53

    Journal: American Journal of Physiology - Cell Physiology

    Article Title: Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum

    doi: 10.1152/ajpcell.00406.2012

    Figure Lengend Snippet: G601S and Bap31 show a similar sensitivity to brefeldin a (bfa) and nocodazole (noc). A – D : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column), anti-Bap31 (green, second column), and anti-ERGIC-53

    Article Snippet: Cells not expressing Kv11.1 did not show any immunostaining with anti-Kv11.1 (data not shown) nor any of the secondary antibodies alone (data not shown).

    Techniques: Expressing

    G601S selectively colocalizes with Bap31. Shown are representative fluorescent images of cells expressing wild-type (WT)-Kv11.1 or G601S immunostained with anti-Kv11.1 (red, first column) and anti-Derlin-1 ( A ), anti-Bap31 ( B ), anti-Sec31 ( C ), or anti-ERGIC-53

    Journal: American Journal of Physiology - Cell Physiology

    Article Title: Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum

    doi: 10.1152/ajpcell.00406.2012

    Figure Lengend Snippet: G601S selectively colocalizes with Bap31. Shown are representative fluorescent images of cells expressing wild-type (WT)-Kv11.1 or G601S immunostained with anti-Kv11.1 (red, first column) and anti-Derlin-1 ( A ), anti-Bap31 ( B ), anti-Sec31 ( C ), or anti-ERGIC-53

    Article Snippet: Cells not expressing Kv11.1 did not show any immunostaining with anti-Kv11.1 (data not shown) nor any of the secondary antibodies alone (data not shown).

    Techniques: Expressing

    E-4031 treatment decreases G601S and Bap31 colocalization. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second column) in control conditions ( n = 30 images) and

    Journal: American Journal of Physiology - Cell Physiology

    Article Title: Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum

    doi: 10.1152/ajpcell.00406.2012

    Figure Lengend Snippet: E-4031 treatment decreases G601S and Bap31 colocalization. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second column) in control conditions ( n = 30 images) and

    Article Snippet: Cells not expressing Kv11.1 did not show any immunostaining with anti-Kv11.1 (data not shown) nor any of the secondary antibodies alone (data not shown).

    Techniques: Expressing

    Pharmacological correction increases the terminal glycosylation of G601S in cells treated with cycloheximide. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second

    Journal: American Journal of Physiology - Cell Physiology

    Article Title: Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum

    doi: 10.1152/ajpcell.00406.2012

    Figure Lengend Snippet: Pharmacological correction increases the terminal glycosylation of G601S in cells treated with cycloheximide. A : representative fluorescent images of cells expressing G601S immunostained with anti-Kv11.1 (red, first column) and anti-Bap31 (green, second

    Article Snippet: Cells not expressing Kv11.1 did not show any immunostaining with anti-Kv11.1 (data not shown) nor any of the secondary antibodies alone (data not shown).

    Techniques: Expressing

    Immunohistochemistry of the Kv11.1 channels in the placental arteries of women who gave birth without or with COVID-19 during pregnancy. (A-C) Immunohistochemistry images of three women who gave birth without contracting COVID-19 (40 weeks of gestation). (D-F) Immunohistochemistry images of three women who gave birth (40 weeks of gestation), but contracted COVID-19 at 28, 32, or 36 weeks of gestation. Magnification x200. Arrows indicate remodeled vessels.

    Journal: PLoS ONE

    Article Title: Placental vascular remodeling in pregnant women with COVID-19

    doi: 10.1371/journal.pone.0268591

    Figure Lengend Snippet: Immunohistochemistry of the Kv11.1 channels in the placental arteries of women who gave birth without or with COVID-19 during pregnancy. (A-C) Immunohistochemistry images of three women who gave birth without contracting COVID-19 (40 weeks of gestation). (D-F) Immunohistochemistry images of three women who gave birth (40 weeks of gestation), but contracted COVID-19 at 28, 32, or 36 weeks of gestation. Magnification x200. Arrows indicate remodeled vessels.

    Article Snippet: The sections were stained with hematoxylin and eosin (H & E) and Masson’s trichrome, and immunohistochemistry using the antibody against α-smooth muscle actin and Kv11.1 channel (Alomone Labs, Jerusalem, Israel) was carried out.

    Techniques: Immunohistochemistry